BlueCrest Capital Management’s ResMed RMD Stock Holding History

BlueCrest Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-6,518	Closed	-$678K	–	927
2019 Q1	$678K	Buy	6,518 +3,747	+135%	+$387K	0.03%	384
2018 Q4	$316K	Sell	2,771 -4,467	-62%	-$479K	0.02%	492
2018 Q3	$835K	Sell	7,238 -48,145	-87%	-$5.27M	0.02%	519
2018 Q2	$5.74M	Buy	55,383 +53,005	+2,229%	+$5.36M	0.15%	153
2018 Q1	$234K	Sell	2,378 -2,998	-56%	-$283K	0.01%	1203
2017 Q4	$455K	Buy	+5,376	New	+$444K	0.01%	544
2017 Q2	–	Sell	-8,373	Closed	-$603K	–	1058
2017 Q1	$603K	Buy	+8,373	New	+$579K	0.03%	402
2016 Q2	–	Sell	-7,708	Closed	-$446K	–	1016
2016 Q1	$446K	Sell	7,708 -10,275	-57%	-$582K	0.03%	525
2015 Q4	$966K	Buy	+17,983	New	+$1.01M	0.04%	417
2015 Q2	–	Sell	-42,616	Closed	-$3.06M	–	891
2015 Q1	$3.06M	Buy	+42,616	New	+$2.77M	0.16%	180

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlueCrest Capital Management's RMD Position: Q2 2019 in Review

BlueCrest Capital Management sold out of ResMed (RMD) in Q2 2019, closing a stake of 6,518 shares — an estimated $678K sold.

BlueCrest Capital Management first reported a position in RMD in Q1 2015 and held it in 10 quarters. The position peaked at $5.74M in Q2 2018. 485 funds tracked by Wall St. Rank hold RMD as of Q2 2019.

BlueCrest Capital Management reported no remaining ResMed position as of Q2 2019 after selling out during the quarter.
BlueCrest Capital Management sold 6,518 ResMed shares in Q2 2019, an estimated $678K.
BlueCrest Capital Management first reported a position in ResMed in Q1 2015 and held it in 10 quarters.
BlueCrest Capital Management's ResMed position peaked at $5.74M in Q2 2018.
485 funds tracked by Wall St. Rank held ResMed as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.